Clinical Trials Insight: 700030491
Phase of Trial: Phase II
Latest Information Update: 14 Jan 2010
At a glance
- Drugs Davunetide (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- Sponsors Allon Therapeutics
- 13 Jan 2009 Phase II trial will be initiated in 2009, according to an Allon Therapuetics media release.
- 11 Feb 2008 New trial record.